1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RNASE2 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA CLDN4 CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA MRGPRG CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA TSNARE1 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA CLIC4 CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA MCEMP1 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA TST CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA CACNA1S CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA LAD1 CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA PLPPR3 CTRPv2 pan-cancer AAC 0.15 2e-05
Download CSV